Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
PDA Journal of Pharmaceutical Science and Technology
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
PDA Journal of Pharmaceutical Science and Technology

Advanced Search

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • Follow pda on Twitter
  • Visit PDA on LinkedIn
  • Visit pda on Facebook
Research ArticleResearch

Stopper Movement and Headspace (Air Bubble Size) Limitations for 2.25 mL Prefilled Syringe

Christina Evans, Yusuf Oni, Daniel Paniagua, Jason Franck, Charles Dahlheim and Ankur Kulshrestha
PDA Journal of Pharmaceutical Science and Technology November 2023, 77 (6) 472-484; DOI: https://doi.org/10.5731/pdajpst.2022.012749
Christina Evans
1Drug Product Development, Global Product Development & Supply, Bristol Myers Squibb Company, 1 Squibb Drive, New Brunswick, NJ 08901; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Christina.Evans@bms.com
Yusuf Oni
1Drug Product Development, Global Product Development & Supply, Bristol Myers Squibb Company, 1 Squibb Drive, New Brunswick, NJ 08901; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel Paniagua
1Drug Product Development, Global Product Development & Supply, Bristol Myers Squibb Company, 1 Squibb Drive, New Brunswick, NJ 08901; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jason Franck
2Manufacturing Science & Technology, Global Product Development & Supply, Bristol Myers Squibb Company, 1 Squibb Drive, New Brunswick, NJ 08901
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles Dahlheim
1Drug Product Development, Global Product Development & Supply, Bristol Myers Squibb Company, 1 Squibb Drive, New Brunswick, NJ 08901; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ankur Kulshrestha
1Drug Product Development, Global Product Development & Supply, Bristol Myers Squibb Company, 1 Squibb Drive, New Brunswick, NJ 08901; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

Abstract

The sterile barrier is one of the most important aspects of the container closure integrity (CCI) for a prefilled syringe (PFS or syringe). This crucial barrier enables the protection of the syringe contents from contamination. The plunger stopper (stopper) is naturally in a stationary position that is controlled by the static friction between the plunger stopper and the syringe barrel wall. When an applied force is greater than the static friction, which is commonly known as the break-loose force, the plunger stopper will move. In such conditions, the stopper movement can further be increased if an air bubble (AB) is introduced between the liquid fill in the syringe and the stopper during the stoppering process. This additional movement can occur when the pressure differential between the gaseous headspace inside the syringe and the external atmosphere is large enough that the force exerted on the stopper exceeds the break-loose force of the syringe. This can occur during altitude or temperature changes incurred during aerial or mountainous transport. This article, therefore, discusses the relationship between stopper movement and initial headspace (air bubble size/ABS) in a 2.25 mL Type I glass syringe using theoretical and empirical approaches. The results showed the maximum initial headspace needed to enable CCI at specified altitudes and plunger stopper movements for the syringe-plunger stopper combination used in the study. Empirical data also indicated that CCI can be maintained for this syringe-plunger stopper combination with up to 9.0 mm initial headspace at altitudes up to 17,000 feet.

  • 2.25ML PFS
  • CCI
  • Container closure integrity
  • PFS
  • Prefilled syringe
  • Sterile barrier
  • © PDA, Inc. 2023
View Full Text

PDA members receive access to all articles published in the current year and previous volume year. Institutional subscribers received access to all content. Log in below to receive access to this article if you are either of these.  

If you are neither or you are a PDA member trying to access an article outside of your membership license, then you must purchase access to this article (below). If you do not have a username or password for JPST, you will be required to create an account prior to purchasing. 

Full issue PDFs are for PDA members only.

Note to pda.org users

The PDA and PDA bookstore websites (www.pda.org and www.pda.org/bookstore) are separate websites from the PDA JPST website. When you first join PDA, your initial UserID and Password are sent to HighWirePress to create your PDA JPST account. Subsequent UserrID and Password changes required at the PDA websites will not pass on to PDA JPST and vice versa. If you forget your PDA JPST UserID and/or Password, you can request help to retrieve UserID and reset Password below.

Log in using your username and password

Forgot your user name or password?

Log in through your institution

You may be able to gain access using your login credentials for your institution. Contact your library if you do not have a username and password.
If your organization uses OpenAthens, you can log in using your OpenAthens username and password. To check if your institution is supported, please see this list. Contact your library for more details.

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.

patientACCESS

patientACCESS - Patients desiring access to articles

Full issue PDFs are for PDA members only. You can join PDA at www.pda.org. 

PreviousNext
Back to top

In This Issue

PDA Journal of Pharmaceutical Science and Technology: 77 (6)
PDA Journal of Pharmaceutical Science and Technology
Vol. 77, Issue 6
November/December 2023
  • Table of Contents
  • Index by Author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on PDA Journal of Pharmaceutical Science and Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Stopper Movement and Headspace (Air Bubble Size) Limitations for 2.25 mL Prefilled Syringe
(Your Name) has sent you a message from PDA Journal of Pharmaceutical Science and Technology
(Your Name) thought you would like to see the PDA Journal of Pharmaceutical Science and Technology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
2 + 17 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Stopper Movement and Headspace (Air Bubble Size) Limitations for 2.25 mL Prefilled Syringe
Christina Evans, Yusuf Oni, Daniel Paniagua, Jason Franck, Charles Dahlheim, Ankur Kulshrestha
PDA Journal of Pharmaceutical Science and Technology Nov 2023, 77 (6) 472-484; DOI: 10.5731/pdajpst.2022.012749

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Stopper Movement and Headspace (Air Bubble Size) Limitations for 2.25 mL Prefilled Syringe
Christina Evans, Yusuf Oni, Daniel Paniagua, Jason Franck, Charles Dahlheim, Ankur Kulshrestha
PDA Journal of Pharmaceutical Science and Technology Nov 2023, 77 (6) 472-484; DOI: 10.5731/pdajpst.2022.012749
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • 1 Introduction
    • 2 Theory
    • 3 Experimental Methodology
    • 4 Results and Discussion
    • 5 Implications
    • 6 Conclusion
    • Conflict of Interest Declaration
    • References
  • Figures & Data
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Quantitative and Qualitative Evaluation of Microorganism Profile Identified in Bioburden Analysis in a Biopharmaceutical Facility in Brazil: Criteria for Classification and Management of Results
  • Evaluation of Extreme Depyrogenation Conditions on the Surface Hydrolytic Resistance of Glass Containers for Pharmaceutical Use
  • A Holistic Approach for Filling Volume Variability Evaluation and Control with Statistical Tool
Show more Research

Similar Articles

Keywords

  • 2.25ML PFS
  • CCI
  • Container closure integrity
  • PFS
  • prefilled syringe
  • Sterile barrier

Readers

  • About
  • Table of Content Alerts/Other Alerts
  • Subscriptions
  • Terms of Use
  • Contact Editors

Author/Reviewer Information

  • Author Resources
  • Submit Manuscript
  • Reviewers
  • Contact Editors

Parenteral Drug Association, Inc.

  • About
  • Advertising/Sponsorships
  • Events
  • PDA Bookstore
  • Press Releases

© 2025 PDA Journal of Pharmaceutical Science and Technology Print ISSN: 1079-7440  Digital ISSN: 1948-2124

Powered by HighWire